Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton
Pascal Bovet1, Philippe Hirsiger2, Frédéric Emery3, Jessica De Bernardini2, Christophe Rossier3, Josefine Trebeljahr2, Isabelle Hagon-Traub21Institute of Social and Preventive Medicine (IUMSP), University of Lausanne and Centre Universitaire Hospitalier Vaudois (CHUV),...
Guardado en:
Autores principales: | Bovet P, Hirsiger P, Emery F, De Bernardini J, Rossier C, Trebeljahr J, Hagon-Traub I |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ebe69a6c08954526b8b854fe465b1c03 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Corrigendum
por: Bovet P, et al.
Publicado: (2011) -
A Meal Replacement Program for the Treatment of Obesity: A Cost-Effectiveness Analysis from the Swiss Payer’s Perspective
por: Nuijten M, et al.
Publicado: (2021) -
Emerging utility of once-weekly exenatide in patients with type 2 diabetes
por: Goud A, et al.
Publicado: (2015) -
Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
por: Mann KV, et al.
Publicado: (2014) -
Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients
por: MacConell L, et al.
Publicado: (2015)